|
|
|||||||
Hemostasis |
From the Department of Medicine (PJA, EMM, JES) and Howard Hughes Medical Institute (WG, JES), Washington University School of Medicine, St. Louis, MO 63110 USA; Department of Pathology and Medicine, Vanderbilt University, Nashville, TN 37232 (DG); Laboratory for Thrombosis Research, Interdisciplinary Research Center, Katholieke Universiteit Leuven Campus Kortrijk, B-8500 Kortrijk, Belgium (HBF, KV)
Correspondence: Patricia J. Anderson, Department of Medicine, Washington University School of Medicine, 660 S. Euclid, Box 8066, St. Louis, MO 63110 USA. E-mail: tanderso{at}im.wustl.edu
Reportedly, complexes between factor XI and ADAMTS13 are detected with a commercial ADAMTS13/FXI ELISA kit in plasma and are decreased in thrombotic thrombocytopenic purpura (TTP). Using this kit, control and TTP patient plasma contained varying amounts of signal (25–670% of a reference plasma) but no signal was observed for mixtures of recombinant enzymes, suggesting little interaction. ADAMTS13/FXI complexes were undetectable by immunoprecipitation or gel filtration chromatography in control plasma or mixtures of recombinant proteins. These results suggest that ADAMTS13/FXI complexes are insignificant in plasma and unlikely to affect the function of either protein during normal hemostasis or in TTP.
Key words: von Willebrand Factor, factor XI, ADAMTS13.
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |